CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The SUPREME project develops innovative therapeutic strategies to combat multidrug-resistant bacteria using light-activatable nitric oxide photodonors combined with existing antibiotics. By employing biocompatible cyclodextrin polymers, the project aims to enhance the effectiveness of antibiotics and reduce resistance…
With more than 13 million people dying per year from infectious diseases Multidrug Resistance (MDR) in bacteria remains thegreatest challenge in public health care.
This scenario, associated to the low turnover of new clinically approved antibioticdrugs makes the development of innovative therapeutic approaches to fight antibiotic resistance desperately needed toaddress this devastating societal problem.
In this frame, SUPREME aims at the implementation of a novel strategy basedon unprecedented…
UNIVERSITA DEGLI STUDI DI CATANIA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
CYCLOLAB CYCLODEXTRIN R&D LABORATORY LTD
Hungary, Budapest
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Italy, Messina
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
